An Innovative Aid in Early Cancer Diagnosis and Follow up
Oncolab provides the FDA approved AMAS blood test, helping health care professionals to diagnose cancer, and to follow up during treatment. In studies of more than 8,000 patients, the AMASŪ Test was found to be 95% accurate and unique for its diverse use as a diagnostic tool regarding all non-terminal cancers. In some cases, the AMASŪ test detected cancer 1 to 19 months before clinical detection.
This test indicates with great accuracy (99% specificity and 95% sensitivity) if there is cancer active anywhere within your body. Learn more about AMASŪ Test
A free test kit can be ordered through the website or by calling 1-800-922-8378
| Contact Details: |
| 36 The Fenway |
| Boston |
| MA |
| 02215 |
| United States of America |
| Tel: | (800) 922-8378 |
| Fax: | 617 536 0657 |
| Email: | info@oncolabinc.com |
| WWW: | www.oncolabinc.com/
|
|
Loading...
|
Recent Publications by Oncolab Incorporated: |  |
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.
BACKGROUND: Insulin-like growth factor receptor-1 (IGFR-1) represents a... | 3rd June, 2009
| Division of Medical Oncology, Public Hospital, Perugia, Italy.
| Ann Oncol. 2009 May;20(5):842-9. Epub 2009 Jan 19.
DOI Direct Link |
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
AIMS AND BACKGROUND: The aim of this study was to evaluate the... | 30th August, 2008
| Medical Oncology, Azienda
| Tumori. 2008 May-Jun;94(3):398-405.
|
Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival.
BACKGROUND: We explored the correlation between serum human epidermal... | 25th June, 2008
| Medical Oncology Division, Azienda Ospedaliera of Perugia, Perugia, Italy.
| Ann Oncol. 2008 May;19(5):883-90. Epub 2008 Jan 10.
DOI Direct Link |
Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
INTRODUCTION: This prospective study examined association between... | 28th May, 2008
| Medical Oncology Division, Azienda Ospedale Perugia, Via Brunamonti 51,
| J Thorac Oncol. 2008 Apr;3(4):365-73.
DOI Direct Link |
Pathogenic validation of unique germline intronic variants of RB1 in retinoblastoma patients using minigenes.
Precise identification of the pathogenic character of germline mutations... | 29th January, 2008
| OncoLab, Departamento de Biologia Molecular y Celular del Cancer,
| Hum Mutat. 2007 Dec;28(12):1245.
DOI Direct Link |
→View more Oncolab Incorporated research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 748 times since April 2007, the link to the organisation's website has been followed 153 times
Recent Search Terms used to find this page: oncolab | oncolab LOCATIONS | amas test | company oncolab | .
Search for more companies in Boston
Search for more companies in MA
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Oncolab Incorporated
